Company news: Pfizer (PFE) quarterly results beat analysts’ forecasts

Pfizer (PFE) reported Q1 FY 2022 earnings of $1.62 per share (versus $0.95 per share in Q1 FY 2021), beating analysts’ consensus estimate of $1.57 per share.

The company’s quarterly revenues amounted to $25.661 bln (+76.8% y/y), beating analysts’ consensus estimate of $24.734 bln.

The company also issued downside guidance for FY 2022, seeing EPS of $6.25-6.45 versus analysts’ consensus estimate of $7.13 and its prior guidance of $6.35-6.55, and revenues of $98.0-102.0 bln versus analysts’ consensus estimate of $105.9 bln.

PFE fell to $47.70 (-1.32%) in pre-market trading.